Literature DB >> 6119620

3H-WB 4101 binding in the rat vas deferens. Effects of chronic treatments with desipramine and prazosin.

H W Wetzel, M S Briley, S Z Langer.   

Abstract

1. The binding of the alpha-adrenoceptor antagonist ligand, 3H-WB 4101, to membranes prepared from rat vas deferens is rapid, saturable and reversible. 2. Scatchard analyses of the data show the maximal number of binding sites (Bmax) to be 1.528 +/- 0.060 pmoles/g original wet tissue weight and a dissociation constant (Kd) of 0.84 +/- 0.07 nM. 3. Hill plots of the binding data revealed that 3H-WB 4101 binds to a single population of independent sites with no cooperative interactions. 4. The relative order of potencies of alpha-adrenoceptor antagonists for the inhibition of 3H-WB 4101 binding, prazosin greater than phentolamine greater than yohimbine, follows the pattern expected for the alpha 1-type of adrenoceptors. 5. After repeated administration of prazosin to rats (0.4 mg/kg/day for 21 days), 3H-WB 4101 binding showed a significant increase in the density of alpha 1-adrenoceptors (122% of controls). 6. Chronic treatment with desipramine (13.6 mg/Kg/day for 22 days) resulted in a significant decrease in the number of alpha 1-adrenoceptors (79% of controls).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119620     DOI: 10.1007/bf00503814

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states.

Authors:  D A Greenberg; D C Prichard; S H Snyder
Journal:  Life Sci       Date:  1976-07-01       Impact factor: 5.037

2.  INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

Authors:  J GLOWINSKI; J AXELROD
Journal:  Nature       Date:  1964-12-26       Impact factor: 49.962

3.  Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain.

Authors:  D C U'Prichard; D A Greenberg; P P Sheehan; S H Snyder
Journal:  Science       Date:  1978-01-13       Impact factor: 47.728

4.  Quantitative differences between sympathetic nerve terminals.

Authors:  M Fillenz; R M Pollard
Journal:  Brain Res       Date:  1976-06-18       Impact factor: 3.252

Review 5.  Subclassification of alpha-adrenergic receptors by direct binding studies.

Authors:  C L Wood; C D Arnett; W R Clarke; B S Tsai; R J Lefkowitz
Journal:  Biochem Pharmacol       Date:  1979-04-15       Impact factor: 5.858

Review 6.  Postjunctional supersensitivity and subsensitivity of excitable tissues to drugs.

Authors:  W W Fleming; J J McPhillips; D P Westfall
Journal:  Ergeb Physiol       Date:  1973

7.  An electron microscopic study of the innervation of papillary muscles in the rat.

Authors:  A M Novi
Journal:  Anat Rec       Date:  1968-01

8.  Specific tricyclic antidepressant binding sites in rat brain.

Authors:  R Raisman; M Briley; S Z Langer
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

9.  Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.

Authors:  P Greengrass; R Bremner
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

10.  The metabolic fate of prazosin.

Authors:  J A Taylor; T M Twomey; M S von Wittenau
Journal:  Xenobiotica       Date:  1977-06       Impact factor: 1.908

View more
  2 in total

1.  Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats.

Authors:  J P Finberg; A Tal
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

2.  Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.

Authors:  J Sallés; A Badia
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.